Intra-Cellular Therapies Inc (NASDAQ:ITCI)

44.61
Delayed Data
As of Sep 27
 +1.91 / +4.47%
Today’s Change
34.43
Today|||52-Week Range
66.00
-14.77%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization94.9K95.5K101.4K105.1K
 
 
 
 
 
 
Operating ExpensesGross Income-94.9K-95.5K-101.4K-105.1K
 
 
 
 
 
General Expenses43.3M42.5M36.6M39.1M
 
 
 
 
 
Research And Development35.4M33.6M25.0M23.7M
 
 
 
 
 
Total Operating Expenses43.4M42.6M36.7M39.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-43.4M-42.6M-36.7M-39.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-41.5M-40.7M-34.8M-37.4M
 
 
 
 
 
Income Taxes0.000.000.00-1.6K
 
 
Net Income-41.5M-40.7M-34.8M-37.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS54.7M54.8M55.1M55.1M
 
 
 
 
 
Shares To Calculate EPS Diluted54.7M54.8M55.1M55.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.76-$0.75-$0.63-$0.68
 
 
 
 
 
EPS Diluted-$0.76-$0.74-$0.63-$0.68